SOLICITATION NOTICE
66 -- Agilent HPLC-Triple Quadrupole Mass Spectrometer, Brand name or equal. - RFQ
- Notice Date
- 8/19/2010
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 334510
— Electromedical and Electrotherapeutic Apparatus Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-SOL-1072483
- Archive Date
- 9/10/2010
- Point of Contact
- Ariana Nijaradze, Phone: 3018277161
- E-Mail Address
-
ariana.nijaradze@fda.hhs.gov
(ariana.nijaradze@fda.hhs.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- Attached is the complete solicitation. This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only 100% small business set-aside solicitation; proposals are being requested and a written solicitation will not be issued. Simplified acquisition procedures and the resultant purchase order will include all applicable provisions and clauses in effect through the Federal Acquisition Circular 05-44. Solicitation number FDA-SOL- 1072483 is issued as a Request for Quotation (RFQ). This synopsis, NAICS code 334510, size standard 500, is to notify contractors that the government intends to issue a Firm Fixed Price Purchase Order in accordance with FAR Part 13.106 for the following statement of work, under the simplified acquisition procedures. The Government reserves the right to award a contract without discussions if the Contracting Officer determines that the initial offer(s) is/are providing the Best Value and discussions are not necessary. PART 2: CONTRACT The government anticipates a firm fixed price contract for an Agilent HPLC-Triple Quadrupole Mass Spectrometer, Brand name or equal. All offerors shall provide lease and purchase pricing. 2.1 Period of Performance: The period of performance is one (1) base year plus three (3) option years. See the attached complete solicitation.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-SOL-1072483/listing.html)
- Record
- SN02247897-W 20100821/100820000501-e6cf1d4c4df3f3765c6961e241b8b877 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |